RESUMO
BACKGROUND: The therapy for open abdomen remains challenging. Abdominal vacuum therapy seems to simplify the treatment and to enable a direct fascial closure in a high percentage of the patients. PATIENTS AND METHODS: A retrospective analysis of 82 consecutive patients who underwent abdominal vacuum therapy between January 2005 and December 2007 was undertaken. Indications, -duration of treatment, complications as well as rate and type of abdominal wall closure were evaluated. RESULTS: The 82 consecutive patients consisted of 46 % female and 54 % male patients with a median age of 65.5 years. The most frequent diagnoses were colorectal carcinoma (24 %, n = 28, colon n = 18 and rectum n = 10), inflammatory bowel dis-ease (13 %), perforated peptic ulcer (9 %), necrotising pancreatitis (7 %), peritoneal carcinosis (5 %), ileus (5 %) and mesenteric ischaemia (4 %). The predominant indication for vacuum therapy was peritonitis (88 %). Vacuum therapy treatment was applied for a median of 6 days (range: 1-73 days). 18 patients (22 %) received intraabdominal foam dressings without the fenestrated polyurethane layer. In 70 % of all cases the abdominal vacuum therapy was performed without complications. 16 patients (19.5 %) developed intestinal fistulas. However, fistulas were not observed among the patients who were treated with foam dressings without a polyurethane layer. Abdominal bleeding was observed in 8 patients (10 %) and a persistent abdominal compartment syndrome was seen in one patient. Nine patients (11 %) died during hospitalisation. After completion of the intraabdominal vacuum therapy, -direct fascial closure was feasible in 35 patients (43 %). In 47 patients (57 %) an absorbable synthetic mesh was required for fascial closure. Symptomatic incisional hernias -occurred in 22 % of the patients. CONCLUSION: Abdominal vacuum therapy simplifies the treatment of patients with abdominal catastrophes such as peritonitis or necrotising pancreatitis. The cost-effective intraperitoneal use of a foam dressing without a fenestrated polyurethane layer was possible without an increased rate of fistulas. This retrospective analysis demonstrates that abdominal vacuum therapy can be performed without complications in the majority of patients. Furthermore, direct fascial closure is possible in almost half of the patients.
Assuntos
Parede Abdominal/cirurgia , Gastroenteropatias/cirurgia , Neoplasias Gastrointestinais/cirurgia , Tratamento de Ferimentos com Pressão Negativa/métodos , Peritonite/cirurgia , Complicações Pós-Operatórias/cirurgia , Cicatrização/fisiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias Colorretais/cirurgia , Fasciotomia , Feminino , Hérnia Abdominal/cirurgia , Humanos , Doenças Inflamatórias Intestinais/cirurgia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Telas CirúrgicasRESUMO
BACKGROUND/AIMS: Alcoholic liver disease is continuously increasing in developed countries being a leading cause of death worldwide. Chronic ethanol consumption induces oxidative stress by accumulation of reactive oxygen intermediates (ROI) while reducing the cellular antioxidant defense. Induction of heme oxygenase-1 (HO-1) may protect primary human hepatocytes (hHeps) from such damage. Thus, the aim of this study was to investigate the potential of polyphenols to protect hHeps from ethanol-dependent oxidative damage. METHODS: hHeps were isolated by collagenase perfusion. ROI and cellular glutathione (GSH) were measured by fluorescent-based assays. Cellular damage was determined by lactate dehydrogenase (LDH) leakage and staining for apoptosis and necrosis. Nuclear translocation of Nrf2 and HO-1 expression were analyzed by Western blot. RESULTS: Ethanol and TGF-ß rapidly increase ROI and reduce GSH in hHeps, causing apoptosis with a release of approximately 40% total LDH after 72 h. Similar to incubation with hemin preincubation and co-incubation of cells with nifedipine, verapamil and quercetin significantly reduce oxidative stress and resulting cellular damage, in a dose-dependent manner, by initiating nuclear translocation of Nrf2 which in turn induces HO-1 under the control of p38 and ERK. Blocking of HO-1 activity with ZNPP9 reverses the protective effect of all three substances. CONCLUSION: Our results suggest that increasing HO-1 activity in hHeps protects them from oxidative stress-dependent damage. As polyphenols have great potential to induce HO-1 expression, they may play an important role for future therapeutic strategies to protect liver from oxidative stress-dependent damage observed during chronic alcohol consumption.
Assuntos
Heme Oxigenase-1/metabolismo , Hepatopatias Alcoólicas/enzimologia , Hepatopatias Alcoólicas/prevenção & controle , Substâncias Protetoras/metabolismo , Soluções Tampão , Citoproteção/efeitos dos fármacos , Etanol/toxicidade , Flavonoides/farmacologia , Hepatócitos/efeitos dos fármacos , Hepatócitos/enzimologia , Hepatócitos/metabolismo , Hepatócitos/patologia , Humanos , L-Lactato Desidrogenase/metabolismo , Hepatopatias Alcoólicas/patologia , Modelos Biológicos , Estresse Oxidativo/efeitos dos fármacos , Fenóis/farmacologia , Polifenóis , Fator de Crescimento Transformador beta/toxicidade , Regulação para Cima/efeitos dos fármacosRESUMO
Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are intraductally located, mucin-producing cystic neoplasms of the pancreas with a malignant potential. We report about a 54-year-old female who underwent segmental resection of the pancreas for non-invasive IPMN. The surgical margins were tumour-negative. Three years later a highly suspicious tumour of the pancreatic tail was detected during routine follow-up. Resection of the pancreatic tail was performed. The histological analysis revealed an adenocarcinoma. This case suggests the development of a pancreatic carcinoma from a non-invasive IPMN and raises the question about the extent of surgery of non-invasive IPMNs of the pancreas.
Assuntos
Adenocarcinoma/cirurgia , Carcinoma Ductal Pancreático/cirurgia , Cistadenoma Mucinoso/cirurgia , Cistadenoma Papilar/cirurgia , Neoplasias Primárias Múltiplas/cirurgia , Adenocarcinoma/diagnóstico por imagem , Adenocarcinoma/patologia , Carcinoma Ductal Pancreático/classificação , Carcinoma Ductal Pancreático/diagnóstico por imagem , Carcinoma Ductal Pancreático/patologia , Cistadenoma Mucinoso/classificação , Cistadenoma Mucinoso/diagnóstico por imagem , Cistadenoma Mucinoso/patologia , Cistadenoma Papilar/classificação , Cistadenoma Papilar/diagnóstico por imagem , Cistadenoma Papilar/patologia , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias Primárias Múltiplas/diagnóstico por imagem , Neoplasias Primárias Múltiplas/patologia , Pâncreas/patologia , Pancreatectomia , Radiografia , ReoperaçãoAssuntos
Educação de Pós-Graduação em Medicina/legislação & jurisprudência , Cirurgia Geral/educação , Corpo Clínico Hospitalar/legislação & jurisprudência , Admissão e Escalonamento de Pessoal/legislação & jurisprudência , Currículo/normas , Europa (Continente) , Humanos , Garantia da Qualidade dos Cuidados de Saúde/legislação & jurisprudênciaRESUMO
BACKGROUND AND OBJECTIVE: Intestinal transplantation (ITx) is the only causal therapy of short bowel syndrome (SBS). Long-term survival after ITx has been improved significantly during the last years. The experience with ITx at the Charite, Campus Virchow Klinikum, are described and discussed. PATIENTS AND METHODS: Twelve isolated ITx and one multivisceral transplantation (including stomach, pancreatodudenal complex, small intestine, liver, ascending colon, right kidney, and adrenal gland) were performed. Mean recipient age was 37.7+/-10.6 yrs (median: 35 yrs; range: 27 - 58 yrs; M:F = 8:5). All patients had irreversible SBS (0 - 30 cm residual bowel length; mean: 11.8+/-11.4 cm; median: 13 cm). RESULTS: 6-months and 1-year patient and graft survival were 85 % (11/13) and 77 % (10/13), respectively. Reasons for graft loss and patient death were necrotizing enterocolitis, severe, muromonab-resistent, acute rejection, and graft ischemia due to complex coagulopathy. All other patients had good long-term outcome. They received enteral nutrition at six hours after operation and were persistently off total parenteral nutrition (TPN) by week two after ITx. CONCLUSION: ITx as established in our centre, with 1-year-patient and graft survival rates of 77 %, reflects current international standard. ITx is complementary to conservative and other operative methods of treating SBS. Referral and indication criteria need wider dissemination to prevent life-threatening complications of TPN.
Assuntos
Intestinos/transplante , Síndrome do Intestino Curto/cirurgia , Adolescente , Glândulas Suprarrenais/transplante , Adulto , Berlim , Criança , Nutrição Enteral , Enterocolite Necrosante/complicações , Feminino , Seguimentos , Rejeição de Enxerto , Sobrevivência de Enxerto , Humanos , Imunossupressores/uso terapêutico , Intestino Delgado/transplante , Transplante de Rim , Transplante de Fígado , Masculino , Pessoa de Meia-Idade , Transplante de Pâncreas , Nutrição Parenteral Total/efeitos adversos , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/prevenção & controle , Síndrome do Intestino Curto/terapia , Estômago/transplante , Taxa de Sobrevida , Fatores de Tempo , Doadores de Tecidos/estatística & dados numéricosAssuntos
Imunossupressores/uso terapêutico , Intestino Delgado/transplante , Transplante Homólogo/imunologia , Adulto , Biópsia , Emprego , Fator XIII/uso terapêutico , Rejeição de Enxerto/epidemiologia , Sobrevivência de Enxerto/fisiologia , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Infecções/epidemiologia , Mucosa Intestinal/patologia , Pessoa de Meia-Idade , Muromonab-CD3/uso terapêutico , Seleção de Pacientes , Complicações Pós-Operatórias/epidemiologia , Qualidade de Vida , Síndrome do Intestino Curto/cirurgia , Doadores de TecidosAssuntos
Intestino Delgado/cirurgia , Intestino Delgado/transplante , Transplante Homólogo/métodos , Adulto , Biópsia por Agulha , Sobrevivência de Enxerto , Teste de Histocompatibilidade , Humanos , Imuno-Histoquímica , Mucosa Intestinal/patologia , Complicações Pós-Operatórias/patologia , Síndrome do Intestino Curto/cirurgia , Coleta de Tecidos e Órgãos/métodos , Transplante Homólogo/fisiologiaAssuntos
Imunossupressores/uso terapêutico , Intestino Delgado/transplante , Complicações Pós-Operatórias/classificação , Transplante Homólogo/imunologia , Adulto , Quimioterapia Combinada , Seguimentos , Sobrevivência de Enxerto , Humanos , Pessoa de Meia-Idade , Complicações Pós-Operatórias/epidemiologia , Fatores de Tempo , Resultado do TratamentoAssuntos
Sobrevivência de Enxerto/fisiologia , Intestino Delgado/transplante , Veias Mesentéricas/cirurgia , Síndrome do Intestino Curto/cirurgia , Transplante Homólogo/métodos , Anastomose Cirúrgica , Colo/patologia , Colo/transplante , Quimioterapia Combinada , Humanos , Imunossupressores/uso terapêutico , Mucosa Intestinal/patologia , Mucosa Intestinal/transplante , Intestino Delgado/cirurgia , Taxa de Sobrevida , Fatores de Tempo , Doadores de Tecidos , Coleta de Tecidos e Órgãos/métodos , Transplante Homólogo/mortalidade , Transplante Homólogo/fisiologiaAssuntos
Arginina/farmacologia , Sobrevivência de Enxerto/fisiologia , Mucosa Intestinal/fisiologia , Intestino Delgado/transplante , Metilprednisolona/farmacologia , Traumatismo por Reperfusão/prevenção & controle , Transplante Isogênico/fisiologia , Animais , Sobrevivência de Enxerto/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/transplante , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/fisiologia , Molsidomina/farmacologia , Ratos , Ratos Endogâmicos Lew , Transplante Isogênico/patologia , Vasodilatadores/farmacologiaRESUMO
Mesenteric artery occlusions are rare complications of Thrombangiitis obliterans (Buerger's disease). We report on a 30-year old male with Thrombangiitis obliterans and mesenteric occlusion as a complication of this disease. Because of unclear abdominal pain, laparoscopy was performed which showed small bowel infarction and reduced liver perfusion. After small bowel resection and a second examination, ischemia of the intestinum continued. Angiography was performed, which showed central occlusion of the celiac trunk and the superior mesenteric artery. Relaparotomy with the embolectomy of the superior mesenteric artery, venous bypass from the sup.mes.art. to the hepatic arteries and repeated small bowel resection was performed. The patient recovered completely and was discharged from hospital after 3 weeks. After a further admission to the hospital 3 weeks later with abdominal pain caused by acute occlusion of the right colonic artery and severe ischemia of the right hemicolon, a right hemicolectomy was performed. Now, one year after the last hospital admission, the patient shows no sign of having any abdominal problems.
Assuntos
Oclusão Vascular Mesentérica/etiologia , Tromboangiite Obliterante/complicações , Adulto , Angiografia , Arteriopatias Oclusivas/diagnóstico , Prótese Vascular , Artéria Celíaca , Colectomia , Colo/irrigação sanguínea , Embolectomia , Seguimentos , Artéria Hepática/cirurgia , Humanos , Intestino Delgado/irrigação sanguínea , Laparotomia , Masculino , Artérias Mesentéricas/cirurgia , Oclusão Vascular Mesentérica/diagnóstico , Oclusão Vascular Mesentérica/diagnóstico por imagem , Oclusão Vascular Mesentérica/cirurgia , Reoperação , Tromboangiite Obliterante/diagnóstico , Tromboangiite Obliterante/diagnóstico por imagem , Fatores de TempoRESUMO
Abstract. We performed 343 vascular reconstructions of the supraaortal arteries from April 1996 to April 2000. Of these patients, 30 underwent combined vascular reconstructions - 22 combined extrathoracal and 8 combined transthoracal reconstructions. In 15 patients, carotid endarterectomy was combined with other cervical surgical interventions. In 10 patients, the vascular operation was combined with surgical interventions in other regions. No permanent complications were observed 8-52 months postoperatively, with the exception of one hemiparesis in the complex vascular operations. Consequently, we recommend the simultaneous surgical approach after careful individual assessment.
Assuntos
Doenças das Artérias Carótidas/cirurgia , Procedimentos Cirúrgicos Operatórios , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças das Artérias Carótidas/mortalidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Operatórios/mortalidade , Resultado do Tratamento , Procedimentos Cirúrgicos Vasculares/mortalidadeAssuntos
Artéria Hepática/fisiologia , Fígado/irrigação sanguínea , Preservação de Órgãos/efeitos adversos , Traumatismo por Reperfusão/fisiopatologia , Resistência Vascular/fisiologia , Adenosina/farmacologia , Alopurinol/farmacologia , Animais , Feminino , Glutationa/farmacologia , Artéria Hepática/efeitos dos fármacos , Insulina/farmacologia , Soluções para Preservação de Órgãos/farmacologia , Rafinose/farmacologia , Reperfusão/métodos , Suínos , Resistência Vascular/efeitos dos fármacosAssuntos
Artéria Hepática/cirurgia , Transplante de Fígado/métodos , Fígado/irrigação sanguínea , Veia Porta/cirurgia , Trombose Venosa/cirurgia , Adulto , Derivação Arteriovenosa Cirúrgica/métodos , Síndrome de Budd-Chiari/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/cirurgiaAssuntos
Rejeição de Enxerto/imunologia , Imunossupressores/uso terapêutico , Transplante de Fígado/imunologia , Receptores de Interleucina-2/imunologia , Anticorpos Monoclonais/uso terapêutico , Soro Antilinfocitário/uso terapêutico , Doença Crônica , Ciclosporina/uso terapêutico , Quimioterapia Combinada , Rejeição de Enxerto/mortalidade , Rejeição de Enxerto/prevenção & controle , Sobrevivência de Enxerto , Humanos , Transplante de Fígado/mortalidade , Risco , Tacrolimo/uso terapêuticoRESUMO
Host defense mechanisms preventing bacterial invasion are particularly important in the gastrointestinal tract, since most gram-negative infections originate from there. Intraepithelial lymphocytes (IEL) seem to play an important role in this immune surveillance of the intestine, although their function in sepsis is not fully understood. To evaluate the characteristics of IEL in sepsis, C57BL/6 mice received a non-lethal dose of LPS and IEL were harvested at various time points thereafter. Although IEL displayed no phenotypic changes after endotoxemia, they displayed enhanced cytolytic activity and increased proliferation after LPS injection In addition, IEL from septic mice showed enhanced gamma interferon (IFN-gamma) production after LPS administration. The production of IFN-gamma may have induced the increased intestinal NOS-2 mRNA expression which was observed after endotoxemia. In conclusion, endotoxemia leads to functional activation of IEL without phenotypic changes. The activation of IEL and the subsequently increased NOS-2 expression may be important mechanisms in maintaining the mucosal barrier after sublethal LPS challenge.
Assuntos
Mucosa Intestinal/patologia , Mucosa Intestinal/fisiopatologia , Linfócitos/fisiologia , Sepse/patologia , Sepse/fisiopatologia , Animais , Divisão Celular , Citotoxicidade Imunológica , Endotoxemia/imunologia , Endotoxemia/patologia , Endotoxemia/fisiopatologia , Feminino , Técnicas In Vitro , Interferon gama/biossíntese , Mucosa Intestinal/imunologia , Intestino Delgado/imunologia , Intestino Delgado/patologia , Intestino Delgado/fisiopatologia , Lipopolissacarídeos/toxicidade , Subpopulações de Linfócitos/efeitos dos fármacos , Subpopulações de Linfócitos/imunologia , Subpopulações de Linfócitos/patologia , Subpopulações de Linfócitos/fisiologia , Linfócitos/efeitos dos fármacos , Linfócitos/imunologia , Linfócitos/patologia , Camundongos , Camundongos Endogâmicos C57BL , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo II , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Sepse/imunologiaRESUMO
Because of the donor shortage, there are concerns for liver transplantation in patients with alcoholic cirrhosis. We therefore analyzed patients transplanted for alcoholic cirrhosis at our center with respect to patient and graft survival, recurrence of disease, and postoperative complications. Out of 1000 liver transplantations performed in 911 patients, 167 patients were transplanted for alcoholic cirrhosis; 91 patients received CsA- and 76 patients FK506-based immunosuppression. Recurrence was diagnosed by patient's or relative's declaration, blood alcohol determination, and delirium. Diagnosis and treatment of acute and chronic rejection was performed as previously described. One- (96.8% versus 91.3%) and 9-year patient survival (83.3% versus 80%) compared well with other indications. Five of 15 patients died due to disease recurrence. Recurrence of disease was significantly related to the duration of alcohol abstinence prior to transplantation. In patients who were abstinent for less than 6 months (17.1%), recurrence rate was 65%, including four of the five patients who died of recurrence. Recurrence rate decreased to 11.8%, when abstinence time was 6-12 months and to 5.5%, when the abstinence times was > 2 years. Next to duration of abstinence, alcohol relapse was significantly related to sex, social environment, and psychological stability. The incidence of acute rejection compared well with other indications (38.1%); CsA: 40.1% versus 33.3% in FK506 patients. In all, 18.2% of CsA patients experienced steroid-resistant rejection compared with 2.6% of FK506 patients. Seven patients (7.6%) in the CsA group and one patient (1.3%) in the FK506 group developed chronic rejection. A total of 57.1% developed infections; 5.7% were life-threatening. CMV infections were observed in 14.3% (versus 25% for other indications). New onset of insulin-dependent diabetes was observed in 8.6% and hypertension in 32.4%. In conclusion, alcoholic cirrhosis is a good indication for liver transplantation with respect to graft and patient survival and development of postoperative complications. FK506 therapy was favourable to CsA treatment. Patient selection is a major issue and established criteria should be strictly adhered to. Patients with alcohol abstinence times shorter than 6 months should be excluded, since recurrence and death due to recurrence was markedly increased in this group of patients.